Sowell Financial Services LLC purchased a new position in Danaher Corporation (NYSE:DHR - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,033 shares of the conglomerate's stock, valued at approximately $1,442,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Mission Wealth Management LP increased its stake in Danaher by 0.7% in the 1st quarter. Mission Wealth Management LP now owns 13,096 shares of the conglomerate's stock worth $2,685,000 after acquiring an additional 96 shares during the last quarter. FARMERS & MERCHANTS TRUST Co OF LONG BEACH grew its holdings in shares of Danaher by 1.6% during the first quarter. FARMERS & MERCHANTS TRUST Co OF LONG BEACH now owns 15,107 shares of the conglomerate's stock worth $3,097,000 after purchasing an additional 241 shares in the last quarter. Brown Miller Wealth Management LLC increased its position in shares of Danaher by 6.6% in the first quarter. Brown Miller Wealth Management LLC now owns 3,508 shares of the conglomerate's stock worth $719,000 after purchasing an additional 218 shares during the last quarter. Bank Pictet & Cie Europe AG lifted its position in Danaher by 1.1% during the first quarter. Bank Pictet & Cie Europe AG now owns 194,910 shares of the conglomerate's stock valued at $39,957,000 after purchasing an additional 2,179 shares during the last quarter. Finally, Tuttle Capital Management LLC grew its stake in Danaher by 59.2% in the 1st quarter. Tuttle Capital Management LLC now owns 2,331 shares of the conglomerate's stock worth $478,000 after buying an additional 867 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Wall Street Analyst Weigh In
DHR has been the subject of a number of research analyst reports. Robert W. Baird dropped their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Barclays lifted their price target on Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 22nd. Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective on the stock in a research report on Friday, March 14th. Guggenheim restated a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Finally, Wall Street Zen lowered Danaher from a "buy" rating to a "hold" rating in a research note on Monday, June 9th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $248.17.
Check Out Our Latest Research Report on DHR
Danaher Trading Down 0.7%
Shares of NYSE:DHR traded down $1.39 during midday trading on Thursday, hitting $194.36. 3,236,239 shares of the stock traded hands, compared to its average volume of 3,488,121. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The business's 50 day moving average is $193.46 and its two-hundred day moving average is $210.32. The stock has a market capitalization of $139.10 billion, a PE ratio of 37.74, a P/E/G ratio of 2.73 and a beta of 0.77. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. As a group, research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.66%. Danaher's dividend payout ratio (DPR) is currently 24.85%.
Insider Buying and Selling at Danaher
In related news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.
Danaher Company Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
